{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-169285","form_type":"8-K","ticker":"HOWL","cik":"0001785530","company_name":"Werewolf Therapeutics, Inc.","filed_at":"2022-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.309269+00:00","generated_at":"2026-06-25T04:01:32.614271+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"confidence":"high","headline":"Werewolf Therapeutics announces annual meeting voting results; directors elected and auditor ratified","bullets":["Stockholders elected Briggs Morrison and Michael Sherman as Class I directors for three-year terms ending in 2025.","Ratification of Deloitte & Touche as auditor for FY2022 passed with 23,945,185 votes for, 1,694 against, 12 abstain.","Broker non-votes on director elections totaled 3,626,970.","No other material proposals were presented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-169285","json":"https://secwatch.observer/filing/0001193125-22-169285.json","markdown":"https://secwatch.observer/filing/0001193125-22-169285.md","text":"https://secwatch.observer/filing/0001193125-22-169285.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1785530/000119312522169285/0001193125-22-169285-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1785530/000119312522169285/d286266d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T04:01:32.614271+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}